Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Tim-3 mediates T cell trogocytosis to limit antitumor immunity

Journal Article · · J. Clin. Invest.
DOI:https://doi.org/10.1172/JCI152864· OSTI ID:1901234

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
DOE - Office Of Science; FOREIGN
OSTI ID:
1901234
Journal Information:
J. Clin. Invest., Vol. 132, Issue (9)
Country of Publication:
United States
Language:
ENGLISH

References (48)

Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection journal November 2008
Restoring function in exhausted CD8 T cells during chronic viral infection journal December 2005
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer journal June 2012
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma journal July 2013
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma journal July 2015
Reversing T-cell Dysfunction and Exhaustion in Cancer journal April 2016
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity journal November 2005
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity journal September 2010
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8 + T cell dysfunction in melanoma patients journal September 2010
Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy journal August 2016
Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade journal February 2019
Progenitor and Terminal Subsets of CD8+ T Cells Cooperate to Contain Chronic Viral Infection journal November 2012
PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors journal March 2014
Targeting novel inhibitory receptors in cancer immunotherapy journal June 2020
TIM3 comes of age as an inhibitory receptor journal November 2019
CEACAM1 regulates TIM-3-mediated tolerance and exhaustion journal October 2014
Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1 journal July 2012
T Cell Immunoglobulin Mucin-3 Crystal Structure Reveals a Galectin-9-Independent Ligand-Binding Surface journal March 2007
T Cell/Transmembrane, Ig, and Mucin-3 Allelic Variants Differentially Recognize Phosphatidylserine and Mediate Phagocytosis of Apoptotic Cells journal January 2010
Promotion of Tissue Inflammation by the Immune Receptor Tim-3 Expressed on Innate Immune Cells journal November 2007
Antigen recognition induces phosphatidylserine exposure on the cell surface of human CD8+ T cells journal December 2006
Lipid order and charge protect killer T cells from accidental death journal November 2019
Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity journal July 2021
The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake journal June 2021
TIM-3 Regulates CD103+ Dendritic Cell Function and Response to Chemotherapy in Breast Cancer journal January 2018
TIM-3 restrains anti-tumour immunity by regulating inflammasome activation journal June 2021
Imprinting of Lymphocytes with Melanoma Antigens Acquired by Trogocytosis Facilitates Identification of Tumor-Reactive T Cells journal April 2013
Antigen-Specific Transfer of Functional Programmed Death Ligand 1 from Human APCs onto CD8+ T Cells via Trogocytosis journal December 2011
Capture of membrane components via trogocytosis occurs in vivo during both dendritic cells and target cells encounter by CD8+T cells journal October 2007
What is trogocytosis and what is its purpose? journal September 2003
TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity: TIM genes: a family of PtdSer receptors journal April 2010
Immunization With Analog Peptide in Combination With CpG and Montanide Expands Tumor Antigen-specific CD8+ T Cells in Melanoma Patients journal October 2008
Epitope Hierarchy of Spontaneous CD4+ T Cell Responses to LAGE-1 journal December 2010
The HIF-1/glial TIM-3 axis controls inflammation-associated brain damage under hypoxia journal March 2015
Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation journal April 2009
The Direction of Plasma Membrane Exchange between Lymphocytes and Accessory Cells by Trogocytosis Is Influenced by the Nature of the Accessory Cell journal January 2010
T cell antigen discovery via trogocytosis journal January 2019
TCR-Mediated Internalization of Peptide-MHC Complexes Acquired by T Cells journal October 1999
T Cell Ig and Mucin Domain–Containing Protein 3 Is Recruited to the Immune Synapse, Disrupts Stable Synapse Formation, and Associates with Receptor Phosphatases journal December 2013
The costimulatory activity of Tim-3 requires Akt and MAPK signaling and its recruitment to the immune synapse journal June 2021
Prospects for TIM3-Targeted Antitumor Immunotherapy journal October 2011
The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations journal August 2016
Expression of Tim-3 drives phenotypic and functional changes in Treg cells in secondary lymphoid organs and the tumor microenvironment journal September 2021
Comprehensive Integration of Single-Cell Data journal June 2019
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets journal April 2019
Features and development of Coot journal March 2010
Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix journal October 2019
Differential expression analysis for sequence count data journal October 2010